Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment frontiersin.org/article/10.338…

“I believe that one day, #immunotherapy is going to be a part of every successful combination that’s used to treat cancer,” says our Dr. Jim Allison: bit.ly/2XodIQA #endcancer

Men are at higher risk of developing severe #COVID19 disease. We investigated whether this difference might be due to the immune response. Fantastic team work by Takehiro Takahashi, MD, PhD et al found that women develop more robust T cell response than men. (1/n) medrxiv.org/content/10.110…

New Perspective in NRI from Sabra Klein Lab Sabra Klein @JennaHaverfield nature.com/articles/s4157… on how biological sex impacts immune responses and COVID-19 outcomes: #SARS_CoV_2 #immunology [link this time!]

The #moghaddamlab just published our work on estrogen and inflammatory signaling in lung cancer! pubmed.ncbi.nlm.nih.gov/32603404/

Many congratulations to Michael Clowers Michael J Clowers for being awarded an NIH/NCI F31 award to study the role of estrogen receptors in restricting tumor-promoting inflammation in lung cancer. We (the Moghaddam laboratory) are so proud of you. GSBS Immunology Program MD Anderson Cancer Center

#AACR2022 is off to a great start!

Keystone Symposium Myeloid is off to a gorgeous start! #KSMyeloid23

Poster time! #KSMyeloid23 GSBS Immunology Program

Excited to share that our work describing the use of STAT3 inhibition in K-ras mutant lung cancer has just been published in Frontiers in Immunology! Check out the full publication here: frontiersin.org/journals/immun…